![conference banner](/images/conference-banner.jpeg)
Abstract
Objective: The primary goal of the present study was to measure the implications of hypoxemia in COVID-19 patients with a history of coronary artery disease (CAD).
Methods: A systematic search of the literature published from November 1, 2019 to May 1, 2021, was conducted on PubMed/MEDLINE, Embase, and Web of Science databases. Afterwards, an observational study was designed based on the electronic health records of COVID-19 patients hospitalized in a tertiary referral hospital during the same period. A total of 179 COVID-19 cases were divided into two groups: cases with a history of CAD and percutaneous coronary intervention (CAD/PCI+, n = 89) and controls (n = 90). Clinical data were extracted from the electronic database of the hospital and statistically analyzed.
Results: After the application of inclusion/exclusion criteria, only three studies were deemed eligible, one of which was concerned with the impact of CAD on the all-cause mortality of COVID-19. Results from our observational study indicated that the cases were older (median age: 74 vs. 45) and more likely to develop hypoxemia (25.8% vs. 8.8%) than the controls. CAD/PCI+ was correlated with a more severe COVID-19 (11% vs. 1%). Age was a moderately significant independent predictor of increased COVID-19 severity, while hypoxemia was not.
Conclusion: Considering the negative impact of hypoxemia on the prognosis of COVID-19 and its higher prevalence among COVID-19 patients with underlying CAD, further research is warranted to unravel the negative effects of COVID-19 on the mechanisms of gas exchange and delivery in patients with pre-existing CAD.
Keywords: Coronavirus disease 2019, COVID-19, percutaneous coronary intervention, angioplasty, hypoxemia, emerging infectious disease.
[http://dx.doi.org/10.1186/s12889-021-10429-0] [PMID: 33632204]
[http://dx.doi.org/10.1136/heartjnl-2020-317901] [PMID: 33334865]
[http://dx.doi.org/10.1016/j.ijid.2020.10.067] [PMID: 33130200]
[http://dx.doi.org/10.1016/j.jiac.2021.07.002] [PMID: 34294527]
[http://dx.doi.org/10.1016/j.autneu.2021.102855] [PMID: 34293703]
[http://dx.doi.org/10.1097/CCE.0000000000000355] [PMID: 33655216]
[http://dx.doi.org/10.1088/1367-2630/16/10/105014] [PMID: 25530704]
[http://dx.doi.org/10.1016/j.jccase.2021.03.009] [PMID: 33897917]
[http://dx.doi.org/10.4244/EIJY15M10_07] [PMID: 26485732]
[http://dx.doi.org/10.1093/cid/ciaa1592] [PMID: 33079200]
[http://dx.doi.org/10.1001/jamasurg.2021.0528] [PMID: 33825815]
[http://dx.doi.org/10.18637/jss.v088.i02]
[http://dx.doi.org/10.1007/164_2019_286] [PMID: 31897610]
[http://dx.doi.org/10.21037/jtd.2016.08.16] [PMID: 27747028]
[http://dx.doi.org/10.1515/9783110646610-028]
[http://dx.doi.org/10.1161/STROKEAHA.120.030365] [PMID: 32466735]
[http://dx.doi.org/10.1161/STROKEAHA.120.030685] [PMID: 32772679]
[http://dx.doi.org/10.1136/openhrt-2020-001428] [PMID: 33229434]
[http://dx.doi.org/10.1016/j.ijchy.2020.100075] [PMID: 33884368]
[http://dx.doi.org/10.1186/s12872-020-01816-3] [PMID: 33413093]
[http://dx.doi.org/10.1016/j.amjcard.2020.08.044] [PMID: 32916148]
[http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.911] [PMID: 34243953]
[http://dx.doi.org/10.1177/0003319715595735] [PMID: 26187640]
![Wayfinder Image](/images/wayfinder.jpg)